Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
absent, accidental, ACMG, ACOG, advice, advocacy, agenda, AI, alongside, alopecia, amortizable, AMP, ANDA, anemia, annuity, anorexia, appraisal, appraised, arguing, art, ASCO, Australia, autosomal, Bachelor, bearing, begun, bifurcation, big, biliary, bioavailability, bioequivalence, bioequivalent, Biologist, biopharma, black, Book, Boston, bound, box, breakthrough, Britain, brochure, budget, budgeted, budgeting, cast, caution, CEO, Chamber, CISO, CISSP, cited, CODM, colon, commonplace, Compassionate, compelled, complicated, compulsory, conceived, concomitant, confirmatory, constrained, contemporaneously, contraindication, Coppel, Council, couple, coupled, credible, cultural, culture, CY, cycle, CYs, dashboard, deficiency, delegating, depositary, detrimental, developmental, dignity, diligence, diligent, diminish, discern, discretionary, dismemberment, displace, dissipated, DLT, documentary, dose, dosing, dropout, dysgeusia, earliest, ease, easier, easily, East, EBITDA, element, emphasize, endpoint, energy, enlarging, ESG, ethnicity, EU, EUR, expenditure, extrapolate, fatigue, FDIC, febrile, feedback, fertility, footage, formula, formulary, fostered, fostering, France, GCP, German, Germany, Google, gradual, Guardant, hard, harmonized, HNSCC, holistic, HTA, ideally, illustrated, IMM, infiltrate, INFORMDX, ingredient, insolvent, inter, intermediate, internet, intravenously, intrusion, invasion, ion, IP, irreversible, issuable, Japan, job, judgement, lapse, led, Leica, length, lengthen, lengthened, leukopenia, lifespan, lifetime, linear, LUMERA, maculopapular, majeure, marker, Middle, MMA, Modernization, modernizing, moiety, molecule, morbidity, mortality, move, MTD, multicenter, nab, nano, nausea, NCE, neuropathy, neutropenia, NIH, NIST, NME, Nominating, notify, notifying, oComparing, oDeveloping, OECD, oForecasted, oHistorical, OIG, oInternal, opposition, Orange, oRelevant, orphan, oTesting, outpatient, overseen, overturn, paradigm, Paragraph, Parliament, PBM, PDUFA, peripheral, PerkinElmer, perpetrated, perpetual, pharmacological, pharmacy, physiological, Pillar, pivotal, plant, plot, pocket, pool, posture, preempt, pregnant, prescription, pride, priority, prophylactic, proportional, provisional, pt, pts, purity, radiographic, randomized, rarity, rash, rationale, reanalyze, reapprove, RECIST, reconsider, recruit, recruiting, recruitment, refrain, regimen, registry, relieve, repaid, repayment, rescinded, restitution, resume, reveal, ribonucleic, risky, RLD, Roe, rolling, route, sacrifice, safer, scanning, Scientist, sensory, shortly, simulate, slower, societal, sporadic, Squibb, stable, stage, Stanford, stipulated, strictly, strongest, sublicensable, sublicense, sublicensee, subpopulation, suggest, suggesting, superior, supervise, supervision, surrogate, suspected, sweeping, swimmer, Switzerland, tabletop, taxane, threat, thriving, tier, tightening, TinyPulse, top, toxicity, toxicology, tract, transient, triage, UK, unanimously, uncovered, uncured, underway, unintentional, unnoticed, user, velocity, verification, violence, vivo, WACC, Wade, waiver, weekly, weigh, whichever, white, withdrawn, withheld, witnessed, Zealand
Removed:
accrual, advancing, advent, analytic, approached, binding, collateral, County, COVID, cumbersome, custodian, developer, draft, dramatically, efficient, efficiently, EFFR, Elmer, enabling, excluding, extraordinary, hereto, Houston, inefficient, infrequently, insignificant, intensified, left, Linkbase, Los, lowered, makeup, manager, nondisclosure, paper, Perkin, play, proportionate, region, RNA, Schema, separated, sequenced, served, spread, Taxonomy, technique, tempered, Temple, today, unpatented, unusual, widespread, XBRL
Filing tables
Filing exhibits
Related press release
Associated FLGT transcripts
FLGT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-272048, 333-270135, 333-248962 and 333-213912 on Form S-8 of our reports dated February 28, 2024, relating to the financial statements of Fulgent Genetics, Inc. and effectiveness of Fulgent Genetics, Inc.’s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2023.
/s/ DELOITTE & TOUCHE LLP
Los Angeles, California
February 28, 2024